Piper Jaffray analyst Brooks West reiterated an Overweight rating and raised his price target on Insulet Corporation (NASDAQ: PODD) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Wedbush Raises Price Target on Insulet (PODD) to $48 Following 2Q Beat August 4, 2016 10:01 AM Leerink Partners Raises Price Target on Insulet (PODD) to $50; Reiterates Outperform August 4, 2016 7:24 AM Insulet (PODD) Tops Q2 EPS by 9c, Lifts Revenue GuidanceAugust 3, 2016 4:04 PM Insulet Reports Second Quarter 2016 Financial ResultsAugust 3, 2016 4:01 PM